CAAS Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-14,358
Closed -$1.12M 1320
2020
Q4
$1.12M Sell
14,358
-300,042
-95% -$22.9M 0.01% 593
2020
Q3
$24.9M Buy
+314,400
New +$24.6M 0.58% 37

Other funds holding MRK

CAAS Capital Management's MRK Position: Q1 2021 in Review

CAAS Capital Management sold out of Merck (MRK) in Q1 2021, closing a stake of 25,646 shares — an estimated $2M sold.

CAAS Capital Management first reported a position in MRK in Q3 2020 and held it in 2 quarters. The position peaked at $9.35M in Q3 2020. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • CAAS Capital Management reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • CAAS Capital Management sold 25,646 Merck shares in Q1 2021, an estimated $2M.
  • CAAS Capital Management first reported a position in Merck in Q3 2020 and held it in 2 quarters.
  • CAAS Capital Management's Merck position peaked at $9.35M in Q3 2020.
  • 2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.